KP profiling is likely to be relevant to the pathogenesis of other diseases characterized by inflammation and neurodegeneration, like Alzheimer’s disease, Parkinson’s disease and ALS, where aberrant KP metabolism has been reported42. This evidence concerns the gene NPPA and early-onset autosomal dominant Alzheimer disease.